Back to News
Market Impact: 0.2
Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Source: PR Newswire
Legal & LitigationCompany Fundamentals
The Law Offices of Howard G. Smith announced a securities fraud class action lawsuit against Capricor Therapeutics, Inc., seeking lead plaintiffs for investors claiming substantial losses. While the notice does not quantify damages, the legal overhang is a potential reputational and financial risk for the company, likely to weigh modestly on sentiment.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment
CAPR-0.90
More News
- Bending Spoons wants to revive software castoffs. Berkshire is backing the plan
- ‘How many canaries have we killed in the coal mine?’ — Wall Street debates if the latest AI bubble warnings are another head fake or the real thing
- States sue OpenAI, saying it gives life to ‘cyberhacking agents’ while ChatGPT hurts children and deceives adults
- Alphabet’s chief investment officer responds to Jefferies warning that the most likely outcome of the AI boom is massive U.S. capital destruction
- A 44-minute call and a memo: How Alexandr Wang won Mark Zuckerberg’s trust—and a $100 billion-plus AI bet
- TSMC posts a sixth straight record profit but turns cautious on 2027